Back to Evidence
Primary experimental recordPositive observation

PMC12839123::ACT034827

C-CR5

Evidence text

Paper-level observation

C-CR5 showed a rapid increase from 30.91% to 97.79% in the same concentration section [50–800 μg/mL].
textConfidence: medium

Assay observation

Activity
Antioxidant
Subtype
Tyrosinase Inhibitor
Measure
percent_inhibition
Comparator
~
Raw observation
30.91% (at 50 μg/mL)
Normalized measurement
~30.91%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
mushroom tyrosinase
Assay method
Not reported by source
Sequence
CYGSR
Standardization
ready simple

Source publication

Comparison of In Vitro Multiple Physiological Activities of Cys–Tyr–Gly–Ser–Arg (CYGSR) Linear and Cyclic Peptides and Analysis Based on Molecular Docking

Biomolecules · 2026

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.